title: A new automated method for analysis of rCBF-SPECT images based on the active-shape algorithm: normal values.
abstract: Most nuclear medicine clinicians use only visual assessment when interpreting regional cerebral blood flow (rCBF) from single-photon emission computed tomography (SPECT) images in clinical practice. The aims of this study were to develop a new, easy to use, automated method for quantification of rCBF-SPECT and to create normal values by using the method on a normal population. We developed a 3-dimensional method based on a brain-shaped model and the active-shape algorithm. The method defines the surface shape of the brain and then projects the maximum counts 0-1.5 cm deep for designated surface points. These surface projection values are divided into cortical regions representing the different lobes and presented relative to the whole cortex, cerebellum or cerebellar maximum. (99m) Tc-hexa methyl propylene amine oxime (HMPAO) SPECT was performed on 30 healthy volunteers with a mean age of 74 years (range 64-98). The ability of the active-shape algorithm to define the shape of the brain was satisfactory when visually scrutinized. The results of the quantification show rCBF values in the frontal, temporal and parietal lobes of 87-88% using cerebellum as the reference. There were no significant differences in normal rCBF values between male and female subjects and only a weak relation between rCBF and age. In conclusion, our new automated method was able to quantify rCBF-SPECT images and create normal values in ranges as expected. Further studies are needed to assess the clinical value of this method and the normal values.
authors.affiliation: Clinical Neurophysiology Unit, Department of Clinical Sciences, Lund University, Sweden. Douglas.Hagerstrom@skane.se
authors.forename: Douglas
authors.initials: D
authors.lastname: Hägerström
authors.forename: David
authors.initials: D
authors.lastname: Jakobsson
authors.forename: Erik
authors.initials: E
authors.lastname: Stomrud
authors.forename: Ann-Margret
authors.initials: AM
authors.lastname: Andersson
authors.forename: Erik
authors.initials: E
authors.lastname: Ryding
authors.forename: Elisabet
authors.initials: E
authors.lastname: Londos
authors.forename: Lennart
authors.initials: L
authors.lastname: Minthon
authors.forename: Ingmar
authors.initials: I
authors.lastname: Rosén
authors.forename: Lars
authors.initials: L
authors.lastname: Edenbrandt
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D001331:Automation; D001921:Brain / Q000098:blood supply*; D002560:Cerebrovascular Circulation; D005260:Female; D006801:Humans; D007090:Image Interpretation, Computer-Assisted / Q000379:methods*; D008297:Male; D008875:Middle Aged; D008955:Models, Cardiovascular; D055420:Perfusion Imaging / Q000379:methods* / Q000592:standards; D049268:Positron-Emission Tomography / Q000592:standards; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals; D012016:Reference Values; D013548:Sweden; D019690:Technetium Tc 99m Exametazime
chemical_list: D019275:Radiopharmaceuticals; D019690:Technetium Tc 99m Exametazime